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Abstract
Background: SET and MYND domain (Smyd) proteins are involved in the transcriptional regulation of cellular proliferation
and development in vertebrates. However, the in vivo functions and mechanisms by which these proteins act are poorly
understood.
Methodology/Principal Findings: We have used biochemical and genetic approaches to study the role of a Smyd protein in
Drosophila. We identified eleven Drosophila genes that encode Smyd proteins. CG14122 encodes a Smyd4 homologue that
we have named dSmyd4. dSmyd4 repressed transcription and recruited class I histone deacetylases (HDACs). A region of
dSmyd4 including the MYND domain interacted directly with ,150 amino acids at the N-termini of dHDAC1 and dHDAC3.
dSmyd4 interacts selectively with Ebi, a component of the dHDAC3/SMRTER co-repressor complex. During embryogenesis
dSmyd4 was expressed throughout the mesoderm, with highest levels in the somatic musculature. Muscle-specific RNAi
against dSmyd4 resulted in depletion of the protein and lead to severe lethality. Eclosion is the final moulting stage of
Drosophila development when adult flies escape from the pupal case. 80% of dSmyd4 knockdown flies were not able to
eclose, resulting in late pupal lethality. However, many aspects of eclosion were still able to occur normally, indicating that
dSmyd4 is likely to be involved in the development or function of adult muscle.
Conclusions/Significance: Repression of transcription by dSmyd4 and the involvement of this protein in development
suggests that aspects of Smyd protein function are conserved between vertebrates and invertebrates.
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Introduction
Development requires the establishment and maintenance of
patterns of gene expression. The activity of a gene is dependent on
both the available repertoire of transcription factors and the local
packaging of DNA into chromatin. Proteins involved in regulation
of chromatin structure can therefore act as important determi-
nants of developmental processes. SET and MYND domain
(Smyd) proteins are conserved from yeast to vertebrates and the
human and mouse genomes each contain five annotated Smyd
proteins. SET domains were first identified in the Drosophila
proteins Su(var)3–9, Enhancer of Zeste and Trithorax [1,2,3].
SET domains catalyse histone methylation [3,4]. SET proteins are
involved in both transcription regulation at specific loci and more
widespread events such as heterochromatin formation [5]. The
SET domains of vertebrate Smyd1, Smyd2 and Smyd3 catalyse
methylation of H3-K4 [6,7,8]. In addition Smyd2 methylates H3-
K36 and the non-histone substrate p53 [9,10]. MYND (Myeloid
translocation protein, Nervy, Deaf) domains are composed of two
zinc fingers that mediate protein-protein interactions [11]. These
domains are found in many proteins that regulate transcription,
but their specific functions in Smyd proteins have not been
determined. In other proteins MYND domains are involved in the
recruitment of histone deacetylase (HDAC) containing complexes
[11,12,13,14]. HDAC complexes are conserved between eukary-
otes and these complexes are recruited as co-repressors to remodel
local chromatin structure [15].
Despite the prevalence of Smyd proteins throughout evolution
their in vivo functions are poorly understood. Recent studies have
implicated Smyd proteins in the transcriptional regulation of
cellular proliferation and differentiation processes [7,16]. Smyd3 is
over-expressed in most hepatocellular and colorectal carcinomas
and a number of gene targets have been identified [7]. Smyd1 is
expressed specifically in muscle tissue and loss-of-function studies
in vertebrates identified an important role for Smyd1 in muscle
development [8,16], but it is unclear how it fulfils this role in vivo.
Drosophila provides a highly tractable system for in vivo studies of
novel genes. We have identified eleven genes encoding Smyd
homologues in the Drosophila genome. Data from gene expression
databases indicate that six of these genes are expressed
predominantly in the mesoderm, which develops to become
muscle. Mesoderm is specified early in Drosophila embryogenesis
[17]. Patterns of gene expression established within the mesoderm
define regions of cardiac, visceral and somatic muscle [18,19]. The
somatic musculature is formed by the fusion and migration of
groups of cells to form a stereotypical pattern of larval musculature
PLoS ONE | www.plosone.org 1 August 2008 | Volume 3 | Issue 8 | e3008[20,21]. During the pupal stage these larval muscles are broken
down and adult muscles are formed from pools of adult myoblasts
specified during embryogenesis [22].
This study provides the first characterisation of a Drosophila
Smyd protein. CG14122 (FlyBase accession number:
FBgn0036282), named Drosophila Smyd4 (dSmyd4) is homologous
to human Smyd4. Like vertebrate Smyd1 and Smyd2, Drosophila
Smyd4 is able to repress transcription. dSmyd4 interacts directly
with Drosophila class I HDACs via their N-termini. dSmyd4 is
expressed throughout the mesoderm of Drosophila embryos and
knockdown of dSmyd4 by RNAi results in lethality, predominantly
at the late pupal stage. dSmyd4 loss-of-function results in a defect
in eclosion of adult flies from the pupal case, suggesting an
important role for dSmyd4 in development.
Results
Identification of Drosophila Smyd proteins
We performed basic local alignment search tool (BLAST)
searches using each of the human Smyd homologues to
comprehensively identify putative Smyd proteins encoded in the
Drosophila genome. We identified eleven genes that contained both
SET and MYND domains. Other BLAST hits were discarded.
CG11160, CG12119, CG14122, CG14590, CG1868, CG18136,
CG7759, CG8378, CG8503, CG9642 and MSTA contained well-
conserved MYND and SET domains compared to human Smyd
homologues (Fig S1). Gene expression data from FlyAtlas and the
Berkeley Drosophila Genome Project in situ project suggest that most
Drosophila Smyd proteins are expressed specifically in muscle, brain
or sex specific tissues (Table S1) [Supplementary Table 1; 23,24].
The subcellular localisation of six of these proteins was analysed.
CG14122, CG1868, CG11160 and CG8378 exhibited predom-
inantly cytoplasmic over-expression patterns, whilst CG12119 was
predominantly nuclear and CG8503 was exclusively cytoplasmic
(Fig S2).
CG14122 is homologous to human Smyd4
The domain structures of CG14122 and human Smyd4 are
shown in figure 1A. CG14122 shares 34% and 40% identity with
theSETandMYND domainsofhumanSmyd4respectively(Fig1B
and C). CG14122 contains a split SET domain common to Smyd
proteins.CG14122alsocontainstetratricopeptiderepeat motifsthat
area feature ofhumanSmyd4,butnototherhumanSmyd proteins.
We have named this protein Drosophila Smyd4 (dSmyd4).
dSmyd4 directly recruits histone deacetylases
Since Smyd proteins are able to modulate transcription, we
analysed the activity of a dSmyd4-LexA fusion at a LexA
dependent promoter (Fig 2A). In a reporter assay in S2 cells
dSmyd4 consistently repressed transcription between two and
four-fold compared to LexA alone. Vertebrate Smyd1 and Smyd2
repress transcription by recruiting HDACs, therefore we tested
whether the mechanism of repression is conserved [9,16]. Both
Drosophila class I HDACs, dHDAC1 and dHDAC3, co-immuno-
precipitated with dSmyd4 (Fig 2B). The MYND domain
containing protein MTG8 is implicated in the recruitment of
Figure 1. CG14122 is homologous to human Smyd4. A, Domain structure of human Smyd4 (hSmyd4) and Drosophila CG14122 (dSmyd4). T,
tetratricopeptide repeat motif; S-, first part of the SET domain; MYND, MYND zinc fingers; -ET, second part of the SET domain, including cysteine-rich
post-SET region. B, Alignment of the SET domains of dSmyd4 and human Smyd4, Smyd1, Smyd2, SUV39h1 and SET7. C, Alignment of the MYND
domains of dSmyd4 and human Smyd4, Smyd1, Smyd2, MTG8 and BS69. In B and C identical residues are shaded black and similar residues are
shaded grey.
doi:10.1371/journal.pone.0003008.g001
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fragment of dSmyd4 including the MYND domain (amino acids
208–377) was able to bind directly to dHDAC1 and dHDAC3. In
pulldown assays GST-MYND interacted with both in vitro
translated dHDAC1 and dHDAC3 (Fig 2C) and recombinant
his6-tagged dHDAC1 and dHDAC3 produced in bacteria (Fig 2D).
Although MYND domains are known to recruit HDAC
containing complexes, a direct interaction between a MYND
domain and HDAC has not previously been demonstrated. To
define this interaction at higher resolution we used pulldown
assays to map the region of interaction (Fig 3). ,150 amino acids
corresponding to the highly conserved N-termini of dHDAC1 and
dHDAC3 were sufficient to bind dSmyd4 GST-MYND. Frag-
ments of dHDAC1 and dHDAC3 lacking the first ,80 amino
acids exhibited only weak binding capacity.
dSmyd4 interacts with Ebi
dHDAC1 and dHDAC3 exist in four independent co-repressor
complexes in Drosophila. dHDAC1 is found in the NuRD, Sin3A
and CoREST complexes, whereas dHDAC3 is a component of
SMRTER, the Drosophila homologue of NCoR/SMRT complex
[15]. We tested whether dSmyd4 co-immunoprecipitated with
additional components of these complexes. dSmyd4 interacted
with Ebi, a component of the dHDAC3/SMRTER complex [25],
but not dMi2 a component of the NuRD complex (Fig 2E), or
Sin3A or CoREST (data not shown). This indicates that dSmyd4
can be specifically engaged with the SMRTER co-repressor
complex rather than participating in general interactions with all
Drosophila HDAC complexes.
dSmyd4 is expressed in the mesoderm
To gain insight into the in vivo function of dSmyd4 we
determined its expression pattern. Over-expressed dSmyd4 was
predominantly cytoplasmic in S2 cells (Fig 4A). We generated an
antibody against dSmyd4 that specifically recognised dSmyd4 in
western blots and immunofluorescence (Fig S3). In S2 cells
endogenous dSmyd4 showed a nuclear preference (Fig 4B).
However, in late stage Drosophila embryos dSmyd4 was restricted
to muscle fibres and staining was strongly localised to the
cytoplasm (Fig 4C). We used in situ hybridisation to confirm
whether dSmyd4 expression was restricted to the muscle lineage
throughout embryogenesis. dSmyd4 mRNA was expressed
throughout the embryonic mesoderm from stage 10 (Fig 4D–K).
dSmyd4 was observed in visceral, cardiac and somatic muscle
precursors and in late embryogenesis dSmyd4 was strongly
expressed in the somatic musculature. This expression pattern
indicates that dSmyd4 may play a role in muscle development or
function.
dSmyd4 loss-of-function causes lethality
We used the Gal4-UAS system [26] to induce RNAi against
dSmyd4 in different tissues. Two independent insertions of the
UAS-RNAi construct were tested, CG14122R-1 and CG14122R-3.
InthepresenceofGal4theseconstructs producelongRNAhairpins
that are processed to produce short interfering RNAs. The viability
of flies carrying one copy of the UAS-RNAi construct and one copy
of a Gal4 driver is summarised in Table 1. Crosses with wild type
(yellowwhite;yw)fliesthatdonotexpressGal4wereusedasanegative
control. Ubiquitous RNAi using Act5C-Gal4 or Da-Gal4 resulted in
severe levels of lethality. To reduce the possibility that an off-target
effect was responsible for this phenotype we specifically induced
RNAi in all muscle tissue using 24B-Gal4 and Mef2-Gal4. Crosses
between these drivers and the stronger UAS-RNAi insertion,
CG14122R-3, also resulted in lethality. However, inducing RNAi
with the neuronal driver Elav-Gal4 caused no reduction in viability
with either UAS-RNAi line.
Figure 2. dSmyd4 represses transcription and interacts with HDACs. A, Activity of dSmyd4-LexA in a LexA dependent reporter assay. The
reporter activity of LexA alone was normalised to a value of one. Results are the mean of three separate transfections. A schematic of the LexA
dependent promoter is shown below. LexA, LexA binding sites; HSE, Drosophila heat shock elements; hsp70 promoter, minimal hsp70 promoter
including TATA box; LUC, firefly luciferase gene. B, dHDAC1-HA and dHDAC3-HA co-immunoprecipitate with dSmyd4-FLAG. Input represents 10% of
lysate used. C, A GST fusion of amino acids 208–377 of dSmyd4 (GST-MYND) or GST alone were used in pulldown assays with in vitro translated
radiolabelled dHDAC1 or dHDAC3. Input represents 5% of in vitro translation reaction used. D, GST-MYND or GST alone were used in pulldown assays
with recombinant dHDAC1-his6 or dHDAC3-his6. Input represents 2% of recombinant protein used. E, Ebi-HA, but not dMi2-HA, co-
immunoprecipitates with dSmyd4-FLAG. Input represents 10% of lysate used.
doi:10.1371/journal.pone.0003008.g002
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failure
We examined the protein level of dSmyd4 when RNAi was
induced with the muscle-specific driver 24B-Gal4. Inducing RNAi
in the mesoderm was sufficient to knockdown almost all dSmyd4
protein expression in adult flies (Fig 5A). The level of a high
molecular weight band recognised by the antibody was also
reduced, suggesting that this is a modified form of dSmyd4. When
RNAi was induced ubiquitously or in the mesoderm we observed
large numbers of dead pupae. These flies had died just prior to, or
during, eclosion, the stage when adult flies escape from the pupal
case. When RNAi was induced in the mesoderm using 24B-Gal4,
fewer than 20% of flies were able to eclose (Fig 5B). Many flies
initiated the eclosion process, but became trapped and died
partially emerged from the case (Fig 5C). Eclosion requires
peristaltic movement of the abdominal muscles to enable flies to
escape from the pupal case [27]. Most knockdown flies were able
to perform rupture of the pupal case and those flies that escaped
far enough also performed normal wing expansion. This
phenotype resembled that of temperature sensitive dMef2 allelic
combinations, raised to the non-permissive temperature during
larval development [28]. dMef2 is expressed throughout muscle
tissue and is required for embryonic muscle development [29,30].
The majority of flies lacking dMef2 during adult myogenesis
survive until the late pupal stage but fail to eclose fully [28]. The
similarities between the eclosion failure phenotype and expression
patterns of dMef2 and dSmyd4 suggest that dSmyd4 is also
required for correct muscle function during eclosion.
Discussion
The Drosophila Smyd family
The Drosophila genome contains eleven Smyd genes, more than
have previously been annotated in the human or mouse genomes.
The large number of family members may allow these proteins to
assume a repertoire of functions, or ensure redundancy between
family members during development. Further analysis of verte-
brate genomes may also reveal larger numbers of Smyd proteins
than had previously been anticipated. Studies in vertebrates show
that individual Smyd proteins control gene expression in order to
fulfil varied functions during development. The tissue specific
expression patterns of Drosophila Smyd family members suggest
that these proteins may play equivalent roles in the development of
specific tissues in this species.
Conserved mechanisms of repression and localisation of
Smyd proteins
dSmyd4 represses transcription and recruits HDACs in a
manner analogous to vertebrate Smyd1 and Smyd2 [9,16]. This
study gives additional insight into the HDAC co-repressors that
are involved in repression by dSmyd4. We have shown that
dSmyd4 interacts with both dHDAC3 and Ebi, components of the
SMRTER co-repressor complex. This contrasts with mammalian
Smyd2 protein, which interacts with the Sin3A-HDAC complex
[9]. We were unable to detect an interaction between dSmyd4 and
HDAC1-containing NuRD, CoREST and Sin3A co-repressors by
immunoprecipitation. Nevertheless, a common feature of dSmyd4
and vertebrate Smyd2 and Smyd1 is the association of a potential
methyltransferase with histone deacetylase activity in a single
complex. This implies that a primary role of these proteins is to co-
ordinate changes in modification status at their target sites.
We have described a direct interaction between dSmyd4 and
the N-terminal regions of dHDAC1 and dHDAC3. There is a
high level of identity between Drosophila and vertebrate class I
HDACs, especially at the N-termini where this interaction occurs,
therefore this interaction may be relevant to recruitment of
HDACs by Smyd family members in other species. The
recruitment of HDAC co-repressor complexes by MYND domains
is also of clinical importance. AML/MTG8 fusions lead to the
aberrant recruitment of HDAC co-repressor complexes in the
development of leukaemia [13]. The MTG8 MYND domain
interacts with components of these complexes, but the interaction
between the MYND domain of MTG8 and HDACs is poorly
described. The novel interaction described here may also apply to
other interactions such as these.
The cytoplasmic over-expression pattern of dSmyd4 resembles
that of vertebrate Smyd2 [9], providing another parallel between
vertebrate and invertebrate Smyd proteins. However, a more
relevant indicator of biological function is the distribution of
Figure 3. Mapping the interaction between dSmyd4 and
dHDAC1 and dHDAC3. A GST fusion of amino acids 208–377 of
dSmyd4 (GST-MYND) or GST alone were used in a pulldown assay with
in vitro translated radiolabelled fragments of dHDAC1 or dHDAC3. The
schematics on the left indicate the fragments used.
doi:10.1371/journal.pone.0003008.g003
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predominantly nuclear in S2 cells. The strong cytoplasmic
localisation of dSmyd4 in embryos suggests that in addition to
its activity as a transcriptional repressor, dSmyd4 may perform
additional cytoplasmic functions, for example the methylation of
non-histone substrates. This raises additional parallels with
Smyd2, since a cytoplasmic role has been suggested for this
protein [6]. The cell-type dependent localisation of endogenous
dSmyd4 raises interesting questions about how the localisation of
dSmyd4 is regulated. The subcellular localisation of human
Smyd3 is regulated in a cell cycle dependent manner and
analogous developmental regulation may be required for the
function of other Smyd proteins such as dSmyd4 [7].
Requirement for dSmyd4 in development
Knockdown of dSmyd4 in muscle tissue resulted in reduced
rates of survival. dSmyd4 was expressed during embryogenesis, yet
the majority of knockdown flies died at the late pupal stage
suggesting that there is a greater requirement for dSmyd4 in
processes involved in adult myogenesis. This may be due to
redundancy between Smyd proteins during embryogenesis since
CG8503 and CG18136 are also expressed in muscle tissue at this
time [24]. The majority of knockdown flies were not able to escape
from the pupal case but performed other eclosion behaviours
normally. The neural networks and signalling required for eclosion
[27] therefore appear to be intact, indicating that dSmyd4 is likely
to play a role in controlling muscle development or function.
Identifying the precise nature of the eclosion defect caused by
dSmyd4 knockdown will be an important step in understanding
the function of this and other Smyd proteins in the development of
multicellular organisms. Much is known about the transcription
factors involved in Drosophila muscle development [29,30,31,32]
but little is understood about how chromatin structure is regulated
Figure 4. dSmyd4 is expressed in the embryonic mesoderm. A, dSmyd4-FLAG was over-expressed in S2 cells and visualised by
immunofluorescence using anti-FLAG. B, Endogenous dSmyd4 in S2 cells was visualised by immunofluorescence using anti-dSmyd4. C, Endogenous
dSmyd4 in late stage Drosophila embryos was visualised by immunofluorescence using anti-dSmyd4. In A, B and C, nuclei were visualised with 49,6-
diamidino-2-phenylindole (DAPI). D–K, In situ hybridisation of dSmyd4 mRNA in developing Drosophila embryos, anterior to the left. D, F, H and J are
lateral views; E, G, I and K are dorsal views. D and E, stage 10 embryo, weak expression of dSmyd4 throughout the mesoderm. F and G, stage 11
embryo, dSmyd4 expression in specified mesoderm. vmp, visceral muscle precursor; cp, cardiac precursor. H and I, stage 12 embryo, dSmyd4 was
expressed at high levels in the somatic muscle (sm) and expression was maintained in visceral muscle (vm). J and K, stage 14 embryo.
doi:10.1371/journal.pone.0003008.g004
Table 1. Viability of Drosophila with induced RNAi (%)
Gal4 driver line UAS-RNAi line
R1/CyO GFP w+ R3/CyO GFP w+
yw 92 105
Elav-Gal4 106 101
Da-Gal4 10
Act5C-Gal4/TM6b Tb 10 7
24B-Gal4 99 5
dMef2-Gal4 101 76
Percentage viability is calculated as the number of unbalanced adult escapers
recovered as a percentage of the number of CyO adult escapers from UAS-RNAi/
CyO GFP w+ x Gal4 crosses. For the UAS-RNAi/CyO GFP w+ x Act5C-Gal4/TM6b
cross the percentage is calculated as the number of unbalanced adult escapers
recovered as a percentage of half the number of CyO adult escapers. Total
progeny from each cross was .100.
doi:10.1371/journal.pone.0003008.t001
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chromatin remodelling during muscle development. Smyd1 is
required for cardiac development in vertebrates [8,16] and a
number of other Drosophila Smyd proteins appear to be specifically
expressed in muscle. These results suggest that members of the
Smyd family play conserved roles in muscle development in both
vertebrate and invertebrate species. Drosophila provides a tractable
system for the analysis of gene function, for example testing genetic
interactions with other genes involved in muscle development.
Analysis of mutants in dSmyd4 and other Smyd genes using this
approach may also shed light on conserved aspects of Smyd
function in vertebrates.
This study presents the first analysis of both Smyd proteins in
Drosophila and of a Smyd4 homologue. It appears that aspects of
mechanism and function are conserved between Drosophila and
vertebrate Smyd proteins. The repression of transcription by
SMRTER complex recruitment and the requirement of dSmyd4
for survival highlight the importance of this protein family as
transcriptional modulators of developmental processes.
Materials and Methods
Identification of Drosophila Smyd homologues
BLAST searches against the Drosophila annotated proteins
database were performed using each of the human Smyd proteins.
Candidate Smyd proteins were analysed for the presence of SET
and MYND domains by reference to Uniprot and direct
comparison with consensus sequences.
Cloning
cDNA clones from the Berkeley Drosophila Genome Project [33]
were obtained from Geneservice (Cambridge, UK): CG11160,
RE25548; CG12119, RE62495; CG14122, RE32936; CG14590,
AT24727; CG1868, LD26420; CG7759, HL04910; CG8378,
LD29892; CG8503, GH11294; dHDAC1, GM14158; dHDAC3,
LD23745. Coding regions were amplified by PCR and cloned into
the S2 expression vector pRmHa3.
S2 cell culture
Drosophila S2 cells (Drosophila Genomics Resource Centre) were
grown at 25uC in Schneider’s Medium supplemented with 10%
foetal calf serum and antibiotics. S2 cells were split the day before
transfection and were plated at a density of 0.5610
6 per well of a
24 well plate on the day of transfection. Cells were transfected
using FuGENE HD (Roche). Expression from pRmHa3 was
induced with 0.7 mM CuSO4.
LexA dependent reporter assay
Drosophila S2 cells were transfected with 50 ng pAc5.1 (Invitro-
gen) encoding dSmyd4 fused to LexA at the C-terminus, or LexA
alone. Cells were co-transfected with 100 ng pRLAct5C, encoding
Renilla luciferase downstream of an Actin5C promoter and 500 ng
pGL2LexA, encoding firefly luciferase downstream of four
interspersed LexA sites/Drosophila heat shock elements and a
minimal hsp70 promoter. The constructs were based on pRL and
pGL2 respectively (Promega). Cells were harvested two days after
transfection. The Dual-Luciferase Reporter system (Promega) was
used to measure firefly and Renilla luciferase luminscence
according to the manufacturer’s directions. Each firefly luciferase
reading was normalised to its partner Renilla luciferase reading to
control for cell number/viability and transfection efficiency.
Results were the mean of three transfections and the mean value
for LexA alone was set to an arbitrary value of one.
Co-immunoprecipitation
S2 cells expressing dSmyd4-FLAG and dHDAC1-HA or
dHDAC3-HA were lysed in IPB250 (20 mM Tris pH 8.0,
250 mM NaCl, 0.4% NP-40, 1 mM DTT, 1 mM EDTA and
Roche protease inhibitors). S2 cells expressing dSmyd4-FLAG and
dMi2-HA, Ebi-HA, Sin3A-HA or CoREST-HA were lysed in
IPB150 (20 mM Tris pH 8.0, 150 mM NaCl, 0.1% NP-40, 1 mM
DTT, 1 mM EDTA and Roche protease inhibitors). Cell extracts
were incubated with anti-FLAG M2 sepharose (Sigma) for 2 h at
4uC. Sepharose was washed extensively in the lysis buffer and
Figure 5. RNAi knockdown of dSmyd4 causes eclosion failure. A, Protein extracts prepared from adult flies were western blotted with anti-
dSmyd4 and anti-histone H3 (H3). Flies in which RNAi was induced in the mesoderm (24B) from CG14122R-3 expressed much lower levels of dSmyd4
compared to flies from control crosses (yw). B, Flies in which RNAi was induced in the mesoderm (24B-Gal4) showed impaired ability to eclose from
the pupal case compared to flies from control crosses (yw). n=171 for both crosses. C, Photographs of CG14122R-3/24B-Gal4 flies that remained
trapped in the pupal case and died during various stages of eclosion.
doi:10.1371/journal.pone.0003008.g005
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proteins were visualised by western blotting with anti-FLAG M2
(1:5000; Sigma) and anti-HA (1:2000; Roche).
HDAC pulldowns
The region encoding the MYND domain fragment of dSmyd4
(amino acids 208–377) was cloned into pGex4T1 (Pharmacia) to
generate an N-terminal GST fusion. GST-MYND was purified in
phosphate buffered saline (PBS) with 0.1% Triton X-100 on
glutathione sepharose.
35S-labelled dHDAC1 and dHDAC3 were
generated by in vitro translation using TNT Quick Coupled
Transcription/Translation System (Promega). 10 mg GST-
MYND bound to glutathione sepharose was incubated with
35S-
labelled dHDAC1 or dHDAC3 in PDB (20 mM Tris pH 8.0,
200 mM NaCl, 50 mM KCl, 0.5% Triton X-100, 1 mM DTT,
1 mM EDTA) for 2 h at 4uC. Sepharose was washed extensively
with PDB. Bound proteins were separated by SDS PAGE and
visualised using a Typhoon scanner (GE Healthcare). dHDAC1-
his6 and dHDAC3-his6 were expressed from pET28 (Novagen)
and were purified on Ni-NTA agarose (Qiagen) according to the
maufacturer’s directions. dHDAC1-his6 and dHDAC3-his6 were
eluted from the agarose by incubation with 250 mM imidazole for
10 min at room temperature. 10 mg GST-MYND bound to
glutathione sepharose was incubated with 20 mg dHDAC1-his6 or
dHDAC3-his6 in HisPDB (20 mM Tris pH 8.0, 150 mM NaCl,
50 mM KCl, 0.25% Triton X-100, 1 mM DTT, 1 mM EDTA)
for 2 h at 4uC. Proteins were separated by SDS PAGE and
visualised by western blotting with anti-polyhis (1:4000; Sigma).
Generation of anti-dSmyd4
A polyclonal antibody against dSmyd4 was raised in rabbits
using the GST-MYND protein fragment. Immunisation was
performed by Eurogentec. GST-MYND was blotted onto
nitcrocellulose membrane and incubated with the final bleed
diluted in PBS. The membrane was washed extensively in PBS
and the antibody was eluted from the membrane in 200 mM
glycine pH 2.5 and immediately neutralised. The affinity purified
antibody specifically recognised dSmyd4 with low background in
western blots (1:2000) and immunofluorescence.
Immunofluorescence
S2 cells were fixed in 4% formaldehyde. Embryos were fixed
and devitellinised according to Kosman et al. [34]. The following
antibody dilutions were used for stainings: anti-FLAG M2 (Sigma),
1:2000; anti-HA 3F10 (Roche), 1:500; anti-dSmyd4, 1:250 for S2
cells, 1:50 for embryos. Alexafluor conjugated secondary antibod-
ies (Molecular Probes) were used at 1:250. Nuclei were visualised
with DAPI (500 ng/mL). Embryos and S2 cells were imaged using
confocal microscopy.
In situ hybridisation
Full-length dSmyd4 cDNA was used to generate a digoxygenin-
labelled anti-sense probe using the DIG labelling kit (Roche)
according to the manufacturer’s directions. Embryos were fixed
according to Kosman et al. [34]. Hybridisation was performed
according to the protocols of Kosman et al. and Tomancak et al.
[24,34] except a 5 min incubation at 90uC was used in place of
proteinase K treatment. Hybridised RNA was visualised with anti-
digoxygenin-alkaline phosphatase and NBT/BCIP (Roche). Embry-
os were staged according to Campos Ortega and Hartenstein [35].
Fly stocks and RNAi
Fly stocks were maintained at 25uC on standard medium. RNAi
was induced using the UAS-Gal4 system [26]. CG14122R-1 and
CG14122R-3 UAS-RNAi lines were obtained from the RNAi fly
project, NIG/MITILS, Japan. UAS-RNAi stocks balanced with
CyO GFP w+ were crossed to a variety of Gal4 expressing drivers:
Act5C-Gal4 (Y. Hiromi, Bloomington Stock centre); Da-Gal4 and
24B-Gal4 (gifts from M. Bienz); Elav-Gal4; Mef2-Gal4 (a gift from S.
Huelsman). Viability of flies containing one copy of the UAS-
RNAi insertion and one copy of a Gal4 driver was compared to
that of CyO flies from the same cross. To analyse the eclosion
defect non-GFP larvae from the crosses CG14122R-3/CyO GFP w+
x 24B-Gal4 and CG14122R-3/CyO GFP w+ x yw were selected and
allowed to develop.
Supporting Information
Table S1 Domain annotation of Drosophila Smyd homologues
Found at: doi:10.1371/journal.pone.0003008.s001 (0.06 MB
DOC)
Figure S1 Alignments of Drosophila Smyd proteins and human
Smyd proteins. A, SET domain. B, MYND domain. The two
MYND domains of CG8503 are denoted zf1 and zf2 respectively.
In A and B identical residues are shaded black and similar residues
are shaded grey.
Found at: doi:10.1371/journal.pone.0003008.s002 (1.21 MB TIF)
Figure S2 Subcellular localisation of Drosophila Smyd proteins
HA-tagged Drosophila Smyd proteins were over-expressed in S2
cells and visualised by immunofluorescence using anti-HA. Nuclei
were visualised with DAPI.
Found at: doi:10.1371/journal.pone.0003008.s003 (8.33 MB TIF)
Figure S3 Anti-dSmyd4 specifically recognises dSmyd4 in
western blots and immunofluorescence. A, dSmyd4-HA was
over-expressed in S2 cells and visualised by immunofluorescence
using anti-HA and anti-dSmyd4. Nuclei were visualised with
DAPI. B, Protein extracts were western blotted with anti-dSmyd4,
pre-immune serum or anti-FLAG. S2 + FLAG, S2 cell extract
with over-expressed dSmyd4-FLAG; S2, S2 cell extract; FLAG IP,
immunoprecipitated dSmyd4-FLAG.
Found at: doi:10.1371/journal.pone.0003008.s004 (3.72 MB TIF)
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